Insiders · Profile

Brunn Carsten

President and CEO at Cartesian Therapeutics. Filing since 2 Dec 2019. CIK 0001760229

Company

Date

Role

Action

Shares

Amount

Of holding

RNAC Cartesian Therapeutics, Inc.

6 Jan 2026

President and CEO

Sold at will

23,766

$162.08K

6.8%

RNAC Cartesian Therapeutics, Inc.

6 Jan 2025

President and CEO

Sold at will

8,708

$146.57K

4.1%

RNAC Cartesian Therapeutics, Inc.

3 Jan 2025

President and CEO

Sold at will

8,563

$143.19K

3.9%

RNAC Cartesian Therapeutics, Inc.

25 Sep 2023

President and CEO

Sold at will

2,932

$3.11K

0.4%

RNAC Cartesian Therapeutics, Inc.

5 Jan 2023

President and CEO

Sold, plan not stated

13,473

$15.21K

1.7%

RNAC Cartesian Therapeutics, Inc.

4 Jan 2023

President and CEO

Sold, plan not stated

27,597

$31.29K

3.3%

RNAC Cartesian Therapeutics, Inc.

5 Dec 2022

President and CEO

Sold, plan not stated

4,522

$6.01K

0.8%

RNAC Cartesian Therapeutics, Inc.

28 Sep 2022

President and CEO

Sold, plan not stated

2,692

$4.47K

0.5%

RNAC Cartesian Therapeutics, Inc.

2 Sep 2022

President and CEO

Sold, plan not stated

4,768

$8.81K

0.9%

RNAC Cartesian Therapeutics, Inc.

2 Mar 2022

President and CEO

Sold, plan not stated

5,443

$9.86K

1.0%

RNAC Cartesian Therapeutics, Inc.

5 Jan 2022

President and CEO

Sold, plan not stated

13,597

$41.96K

2.6%

RNAC Cartesian Therapeutics, Inc.

10 Dec 2021

President and CEO

Sold, plan not stated

17,196

$51.36K

5.3%

RNAC Cartesian Therapeutics, Inc.

2 Dec 2021

President and CEO

Sold, plan not stated

4,746

$14.06K

1.6%

RNAC Cartesian Therapeutics, Inc.

13 Oct 2021

President and CEO

Sold, plan not stated

15,313

$67.22K

5.2%

RNAC Cartesian Therapeutics, Inc.

2 Sep 2021

President and CEO

Sold, plan not stated

4,523

$20.40K

1.9%

RNAC Cartesian Therapeutics, Inc.

2 Jun 2021

President and CEO

Sold, plan not stated

4,806

$21.04K

2.1%

RNAC Cartesian Therapeutics, Inc.

2 Mar 2021

President and CEO

Sold, plan not stated

5,461

$23.26K

2.5%

RNAC Cartesian Therapeutics, Inc.

2 Dec 2020

President and CEO

Sold, plan not stated

3,323

$11.13K

3.2%

RNAC Cartesian Therapeutics, Inc.

2 Sep 2020

President and CEO

Sold, plan not stated

3,364

$8.03K

3.5%

RNAC Cartesian Therapeutics, Inc.

2 Jun 2020

President and CEO

Sold, plan not stated

3,253

$12.56K

3.6%

RNAC Cartesian Therapeutics, Inc.

3 Mar 2020

President and CEO

Sold, plan not stated

3,374

$13.01K

4.1%

RNAC Cartesian Therapeutics, Inc.

2 Dec 2019

President and CEO

Sold, plan not stated

14,272

$21.81K

16.8%

22 decisions on file.